Skip to main content
Clinical Trials/IRCT20190714044196N1
IRCT20190714044196N1
Completed
Phase 3

The effect of hydroalcoholic extract of Berberis fruits integerrima on the lipid profile, antioxidantparameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease

Rafsanjan University of Medical Sciences0 sites42 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Rafsanjan University of Medical Sciences
Enrollment
42
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Suffering from nonalcoholic fatty liver
  • Elevated levels of Aspartate aminotransferase (AST)
  • Alanine aminotransferase (ALT)
  • Age range of 20\-45 years old
  • Signing a declaration of consent

Exclusion Criteria

  • Using alcohol
  • Using daily berberis
  • Having allergy to berberis and its compounds,
  • Patients with diabetes
  • High blood pressure
  • Patient with perceptual disorders
  • Nephrotic syndrome
  • Ischemic heart diseases
  • Patient with chronic liver disease such as hepatitis
  • Pregnancy or lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials